| scholarly article | Q13442814 |
| P50 | author | Vladimir Motin | Q80111580 |
| P2093 | author name string | Vsevolod L Popov | |
| Ashok K Chopra | |||
| Michelle L Kirtley | |||
| Janice J Endsley | |||
| Johnny W Peterson | |||
| Jian Sha | |||
| Elena V Kozlova | |||
| Tatiana E Erova | |||
| Linsey A Yeager | |||
| Sheri M Foltz | |||
| Matthew B Huante | |||
| Irina V Zudina | |||
| Kristin L DeBord | |||
| P2860 | cites work | Structure and biogenesis of the capsular F1 antigen from Yersinia pestis: preserved folding energy drives fiber formation | Q27641384 |
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Yersiniosis. II: The pathogenesis of Yersinia infections | Q33603316 | ||
| Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense | Q33901607 | ||
| Comparative evaluation of three different genotyping methods for investigation of nosocomial outbreaks of Legionnaires' disease in hospitals | Q33967468 | ||
| Diagnosis of bubonic plague by PCR in Madagascar under field conditions | Q33974812 | ||
| Interconversion of Purine Mononucleotides in Pasteurella pestis. | Q34155668 | ||
| A plasminogen-activating protease specifically controls the development of primary pneumonic plague | Q34606584 | ||
| Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. | Q34830777 | ||
| Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae | Q36049296 | ||
| Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. | Q36539626 | ||
| Biogenesis of the fraction 1 capsule and analysis of the ultrastructure of Yersinia pestis | Q36594569 | ||
| Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). | Q36808454 | ||
| Use of an enzyme-linked immunosorbent assay to measure antigenaemia during acute plague | Q36875690 | ||
| Roles of YopN, LcrG and LcrV in controlling Yops secretion by Yersinia pestis. | Q36984033 | ||
| The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague | Q37099458 | ||
| New method for plague surveillance using polymerase chain reaction to detect Yersinia pestis in fleas | Q37128144 | ||
| Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis | Q39654111 | ||
| The basis of virulence in Pasteurella pestis: the development of resistance to phagocytosis in vitro | Q40245703 | ||
| Structural and functional properties of Yersinia pestis Caf1 capsular antigen and their possible role in fulminant development of primary pneumonic plague | Q40662896 | ||
| Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. | Q41142448 | ||
| Comparison of hand-held test kits, immunofluorescence microscopy, enzyme-linked immunosorbent assay, and flow cytometric analysis for rapid presumptive identification of Yersinia pestis | Q41447922 | ||
| The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses | Q41447968 | ||
| Involvement of c-Jun N-terminal kinase in rF1 mediated activation of murine peritoneal macrophages in vitro | Q41457898 | ||
| Phosphorylation of p42/44 MAP kinase is required for rF1-induced activation of murine peritoneal macrophages | Q41458100 | ||
| Recombinant fraction 1 protein of Yersinia pestis activates murine peritoneal macrophages in vitro | Q41461527 | ||
| Evaluation of a standardized F1 capsular antigen capture ELISA test kit for the rapid diagnosis of plague | Q41462697 | ||
| Mu dI1(Ap lac) mutagenesis of Yersinia pestis plasmid pFra and identification of temperature-regulated loci associated with virulence. | Q41464290 | ||
| Short report: Serodiagnosis of plague in humans and rats using a rapid test. | Q41464771 | ||
| Development and testing of a rapid diagnostic test for bubonic and pneumonic plague | Q41469016 | ||
| A major new test for plague | Q41469024 | ||
| Donor strand complementation mechanism in the biogenesis of non-pilus systems | Q41470851 | ||
| Structural and functional similarity between Yersinia pestis capsular protein Caf1 and human interleukin-1 beta. | Q41475912 | ||
| Serodiagnosis of human plague by an anti-F1 capsular antigen specific IgG/IgM ELISA and immunoblot | Q41476731 | ||
| An extended hydrophobic interactive surface of Yersinia pestis Caf1M chaperone is essential for subunit binding and F1 capsule assembly | Q41477423 | ||
| A combination of different polymerase chain reaction (PCR) assays for the presumptive identification of Yersinia pestis | Q41477742 | ||
| Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick | Q41478538 | ||
| Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar | Q41480580 | ||
| F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy | Q41484231 | ||
| Laboratory diagnosis of plague | Q41485799 | ||
| Lack of IL-1 receptor antagonistic activity of the capsular F1 antigen of Yersinia pestis | Q41486296 | ||
| Specific high affinity binding of human interleukin 1 beta by Caf1A usher protein of Yersinia pestis. | Q41493802 | ||
| Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis | Q41494960 | ||
| Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. | Q41498914 | ||
| Development of a diagnostic test for Yersinia pestis by the polymerase chain reaction | Q41499999 | ||
| Identification of encapsulated and non-encapsulated Yersinia pestis by immunofluorescence tests using polyclonal and monoclonal antibodies | Q41516678 | ||
| Potential for rat plague from nonencapsulated variants of the plague bacillus (Yersinia pestis). | Q41527582 | ||
| Chronic infections in laboratory rodents from inoculation of nonencapsulated plague bacilli (Yersinia pestis). | Q41531006 | ||
| Effects of Fraction I from Yersinia pestis on Phagocytosis In Vitro | Q41554324 | ||
| Role of the capsule of Pasteurella pestis in bubonic plague in the guinea pig. | Q41566033 | ||
| An unusual strain of Pasteurella pestis isolated from a fatal human case of plague. | Q41568835 | ||
| The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague. | Q41569171 | ||
| Virulence of Pasteurella pestis | Q41570734 | ||
| Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. | Q41573361 | ||
| Human plague in 1998 and 1999 | Q73540024 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Yersinia pestis | Q153875 |
| P304 | page(s) | 1708-1715 | |
| P577 | publication date | 2011-03-02 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks | |
| P478 | volume | 49 |
| Q38733083 | 'Add, stir and reduce': Yersinia spp. as model bacteria for pathogen evolution |
| Q64137941 | A Bead-Based Flow Cytometric Assay for Monitoring Yersinia pestis Exposure in Wildlife |
| Q37067254 | A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates. |
| Q36553249 | A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague |
| Q41385461 | Application of r-PFE hyperimmune sera for concurrent detection of Bacillus anthracis, Yersinia pestis and staphylococcal enterotoxin B. |
| Q35363899 | Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin |
| Q35187610 | Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague |
| Q36646741 | Deletion of the Braun lipoprotein-encoding gene and altering the function of lipopolysaccharide attenuate the plague bacterium. |
| Q36606805 | Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine |
| Q34575834 | Fast and simple detection of Yersinia pestis applicable to field investigation of plague foci. |
| Q35439470 | High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection. |
| Q46463260 | Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis |
| Q47293934 | Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague |
| Q36316792 | Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague. |
| Q40517577 | On-site detection of bioterrorism-relevant agents : Rapid detection methods for viruses, bacteria and toxins - capabilities and limitations |
| Q40548407 | Pathology and Pathogenesis of Yersinia pestis |
| Q28066875 | Plague Vaccine Development: Current Research and Future Trends |
| Q38813137 | Plague Vaccines: Status and Future |
| Q37889155 | Progress on plague vaccine development |
| Q41212926 | Rapid detection of Yersinia pestis recombinant fraction 1 capsular antigen. |
| Q34359637 | Yersinia pestis intracellular parasitism of macrophages from hosts exhibiting high and low severity of plague |
Search more.